The 63rd Society of Nuclear Medicine and Molecular Imaging Annual Meeting

The 63rd Society of Nuclear Medicine and Molecular Imaging Annual Meeting, held this week in San Diego, CA, brought together more than 5,700 attendees to discuss the latest breakthroughs in the fields of nuclear medicine and molecular imaging.  With  the celebration of the 40th anniversary of FDG, many sessions  revolved around PET/CT imaging, equipment and radiotracers; developed to increase the detection of multiple chronic and complex diseases such as cancer, dementia and cardiac diseases.

Two major PET/CT manufacturers debuted new PET/CT scanners during the annual meeting .  

  • Philips, known for supporting a decade of  PET  and PET/CT technology, showcased their, time-of-flight product Vereos, which Philips calls the world’s first fully digital PET/CT.
  • Siemens debuted the mobile configuration of its recently introduced Biograph Horizon PET/CT system, which delivers high-end functionality for cost-conscious healthcare facilities that do not yet possess the patient volume to support installation of a fixed PET/CT. 

Image Wisely and Image Gently Campaigns were key points in most sessions; addressing concerns about the surge of public exposure to ionizing radiation from medical imaging to both adults and children.  Many sessions presented strong evidence that quality, diagnostic images can be achieved with lower radio-isotope doses for Nuclear Medicine studies and radiation exposure from CT scanners to meet the 2016 MITA/CMS XR-29 guideline.

ROS attended the SNMMI meeting in San Diego. ROS sells pre-owned PET/CT systems, gamma camera systems, and diagnostic imaging equipment to facilities around the world.

As a client manager at Radiology Oncology Systems (ROS), Evan is responsible for providing quality, cost-effective, refurbished equipment solutions to clients worldwide. Evan’s focus is on diagnostic imaging systems, including MRI Scanners, CT Scanners, PET/CT Systems and other imaging systems. Evan and his team may be reached at Info@OncologySystems.com.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top